Comparison of efficacies of haploidentical transplantation and matched sibling donor transplantation in treating T‐cell lymphoblastic lymphoma

Ruowen Wei,Jun Fang,Wei Shi,Xuan Lu,Yingying Wu, Shan Jiang,Ao Zhang,Shanshan Liao,Chunxia Qin,Guohui Cui,Linghui Xia

Cancer Medicine（2023）

引用 1|浏览11

暂无评分

摘要

This study showed that HID-HSCT had comparable effectiveness and safety to MSD-HSCT in treating T-LBL. HID-HSCT could serve as an alternate treatment option for T-LBL in patients without an eligible identical donor. Achievement of the PET/CT-negative status before HSCT may contribute to better survival.

查看译文

关键词

PET/CT,T-cell lymphoblastic lymphoma,allogeneic hematopoietic stem cell transplantation,haploidentical,matched sibling donor

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要